Up to $1.6M is available from NHMRC-JPND Joint Call to assist researchers to participate in multinational collaborative research projects that have been recommended for funding under the European Union JPND.
NHMRC-JPND Joint Call
The NHMRC-JPND Joint Call scheme is a component of the Portfolio Budget Statement Program 1.1: Health and Medical Research, which contributes to Outcome 1: Improved health and medical knowledge. NHMRC works with stakeholders to plan and design the grant program according to the National Health and Medical Research Council Act 1992 (NHMRC Act) and the CGRGs.
NHMRC awards grants through several research funding schemes to advance health and medical knowledge and to improve the health status of all Australians. NHMRC invests in the highest quality research and researchers, as determined through peer review, across the four pillars of health and medical research: biomedical, clinical, public health and health services research.
The objectives of the NHMRC-JPND Joint Call are to:
- provide grants to Australian-based researchers who are participating as collaborators in international consortia under relevant grant opportunities
- provide grants for research being conducted in the area of neurodegenerative disease, particularly Alzheimer’s disease and other dementias under relevant grant opportunities.
The intended outcomes of the NHMRC-JPND Joint Call are:
- increased Australian participation in multi-national collaborations
- increased Australian research capacity in the area of neurodegenerative disease, particularly Alzheimer’s disease and other dementias.
The provisional funding allocation for the NHMRC-JPND JPco-fuND-2 Call for Proposals: Multinational research projects on Personalised Medicine for Neurodegenerative Diseases is estimated to be up to $1.6 million. NHMRC’s Research Committee annually reviews and recommends indicative budget amounts to be awarded across individual funding schemes. Funding will not exceed $0.5 million per grant.
A NHMRC-JPND Joint Call grant can be requested for between one and three years depending on the proposal.
Funding provided by NHMRC for a Research Activity must be spent on costs directly incurred in relation to that Research Activity. Further guidance on the expenditure of funding for a Research Activity is provided in the Direct Research Cost Guidelines on the NHMRC website.
NHMRC-JPND JPco-fuND-2 Call for Proposals: Multinational research projects on Personalised Medicine for Neurodegenerative Diseases funds provide for research cost expenditure in Australia.
Institutions must be an NHMRC approved Administering Institution to be eligible to receive and administer NHMRC funding.
Only Chief Investigators (CIs) whose consortia have been invited by JPND to submit a full application may submit an application to NHMRC.
NHMRC will only fund applications with a key focus on Alzheimer’s disease or other dementias. Applying for funding with any other neurodegenerative disease focus under the JPco-fuND-2 Call for Proposals: Multinational research projects on Personalised Medicine for Neurodegenerative Diseases will not be supported by NHMRC.
Applications close 24 July 2019.